Rasch analysis of the hospital anxiety and depression scale in Parkinson's disease

2008 ◽  
Vol 24 (4) ◽  
pp. 526-532 ◽  
Author(s):  
Maria João Forjaz ◽  
Carmen Rodriguez-Blázquez ◽  
Pablo Martinez-Martin ◽  
2002 ◽  
Vol 25 (6) ◽  
pp. 318-324 ◽  
Author(s):  
Johan Marinus ◽  
Albert F. G. Leentjens ◽  
Martine Visser ◽  
Anne M. Stiggelbout ◽  
Jacobus J. van Hilten

2021 ◽  
Vol 39 (4) ◽  
pp. 312-321
Author(s):  
Jin-Hyuk Choi ◽  
Seongjin Jeon ◽  
Seulgi Hong ◽  
Ahro Kim ◽  
Ji-Yun Park ◽  
...  

Background: Depression and anxiety are prevalent and can cause suffering in patients with Parkinson’s disease (PD). The Korean version of the Hospital Anxiety and Depression Scale (K-HADS) has been widely used to assess depression and anxiety symptoms in Korean patient with PD. The present study aimed to assess the reliability and validity of the K-HADS using Rasch measurement analysis.Methods: A total of 106 PD patients (54 males, 52 females) who met the diagnostic criteria of the United Kingdom Brain Bank were recruited. Unidimensionality, the Rasch model fit, response category functioning, patient-item distribution, and the separation reliability of the K-HADS depression (K-HADS-D) and anxiety (K-HADS-A) subscales were statistically evaluated.Results: The mean K-HADS-D and K-HADS-A scores were 8.08±4.69 (mean±standard deviation) and 5.44±4.18, respectively. Cronbach’s α coefficients of the K-HADS-D and K-HADS-A were 0.82 and 0.83. The Rasch analysis revealed that the K-HADS-D and K-HADS-A showed unidimensionality and no disordered functioning was observed in the 4-point polytomous scale. However, both K-HADS-D and K-HADS-A exhibited suboptimal separation reliability, while the K-HADS-A showed inadequate scale targeting with floor effect.Conclusions: The present study comprises the first validation of the K-HADS using the Rasch measurement model, suggesting that the K-HADS-D and K-HADS-A are clinimetrically acceptable and reliable scales for use in Korean patients with PD. However, the moderate person separation indices implicate the relatively low discriminatory ability of the K-HADS in our study patients.


2009 ◽  
Vol 24 (4) ◽  
pp. 519-525 ◽  
Author(s):  
Carmen Rodriguez-Blazquez ◽  
Belen Frades-Payo ◽  
Maria João Forjaz ◽  
Jesus de Pedro-Cuesta ◽  
Pablo Martinez-Martin ◽  
...  

2013 ◽  
Vol 25 (2) ◽  
pp. 379-390 ◽  
Author(s):  
Sylvie D. Lambert ◽  
Julie F. Pallant ◽  
Allison W. Boyes ◽  
Madeleine T. King ◽  
Benjamin Britton ◽  
...  

2016 ◽  
Vol 22 (1) ◽  
pp. 4 ◽  
Author(s):  
Karl Peltzer ◽  
Supa Pengpid

<p><strong>Objective:</strong> The aim of this study was to estimate the prevalence and relationship of anxiety and depressive features among patients diagnosed with a variety of chronic diseases in three Southeast Asian countries (Cambodia, Myanmar and Vietnam).<br /><strong>Methods:</strong> A cross-sectional survey was conducted in 2014 among 4803 adult patients with chronic diseases who were recruited cross-sectionally from health facilities. Anxiety and depression were assessed with the <em>Hospital Anxiety and Depression Scale</em>.<br /><strong>Results:</strong> Overall, 17.0% of patients screened positive for anxiety disorder and 39.1% for depressive disorder. Patients with cancer (47.8%) had the highest rate of anxiety features, and those with chronic obstructive pulmonary disease (COPD) (62.1%), kidney disease (55.5%), Parkinson’s disease (53.7%) and cardiovascular disorders (CVDs) (52.6%) the highest prevalence of depressive features. Stomach and intestinal diseases, CVDs, migraine or frequent <br />headaches and kidney disease were positively associated with anxiety and depression after adjusting for sociodemographics and illness duration. In addition, cancer and Parkinson’s disease were positively associated with anxiety, and arthritis, diabetes, and COPD were positively associated with depression. In multivariate logistic regression, having two or more chronic conditions and poor quality of life was associated with anxiety and depression.<br /><strong>Conclusion:</strong> Considering the high rate of anxiety and depression among these patients with chronic disease, more efforts should directed to on the psychosocial management of these patients.</p>


2006 ◽  
Vol 15 (9) ◽  
pp. 817-827 ◽  
Author(s):  
A.B. Smith ◽  
E.P. Wright ◽  
R. Rush ◽  
D.P. Stark ◽  
G. Velikova ◽  
...  

2021 ◽  
pp. 1-10
Author(s):  
Keisuke Suzuki ◽  
Ayaka Numao ◽  
Tomoko Komagamine ◽  
Yasuo Haruyama ◽  
Akiko Kawasaki ◽  
...  

Background: The coronavirus disease 2019 (COVID-19) pandemic has negatively affected the mental health of the general population. Objective: We investigated the determinants of quality of life (QOL) in Parkinson’s disease (PD) patients during the COVID-19 pandemic. Methods: Impacts of lifestyle changes due to the COVID-19 pandemic on 100 patients with PD and their caregivers/spouses were assessed. The Hospital Anxiety and Depression Scale was used to assess anxiety and depression. The physical component summary (PCS) and mental component summary (MCS) scores of the short form (SF)-8 were used to evaluate health-related QOL. Results: Regarding health-related QOL, physical function, role physical, general health, vitality and the PCS score were significantly worse in PD patients than in caregivers. Worsening of PD-related symptoms, increased stress, and decreased physical activity were observed in 29.0%, 37.0% and 44.0% of PD patients, respectively. Sixteen patients (16.0%) experienced problems with hospital access, but none reported medication shortages. Strong concerns about COVID-19 were reported by 47.0% of caregivers and 50.0% of PD patients. In PD patients, increased gait disturbance and rigidity, disease severity, smoking, the levodopa equivalent dose and decreased body weight predicted a worse PCS score; anxiety, depression, female sex, stress and long disease duration predicted a worse MCS score. In caregivers, age and smoking contributed to a worse PCS score; depression, stress and worsening patient mood contributed to a worse MCS score. Conclusion: We report the negative impacts of the COVID-19 pandemic on health-related QOL and its determinants in PD patients and their caregivers.


Author(s):  
A Rana ◽  
AM Qureshi ◽  
L Rahman ◽  
MA Rana ◽  
I Abdullah ◽  
...  

The objectives of the study were to analyze the association between Parkinson’s disease and restless legs syndrome, and explore the relationship between mood disorder comorbidity (anxiety and depression), pain, and restless legs syndrome. This study included 123 Parkinson’s disease patients and 123 healthy controls matched for age and gender, and evaluated for anxiety severity, depression severity, pain severity, pain interference, pain disability, and restless legs syndrome prevalence. This was performed using semi-structured interviews and a neurological examination. Restless Legs Syndrome diagnostic criteria and the following inventories were used; Hospital Anxiety and Depression Scale, Brief Pain Inventory, and Pain Disability Index. Parkinson’s disease patients had significantly greater anxiety severity, depression severity, pain severity, pain interference, pain disability, and restless legs syndrome prevalence in comparison to controls. In addition, Parkinson’s disease patients’ comorbid for anxiety and depression had significantly greater pain severity, pain interference, and pain disability, but not RLS prevalence, in comparison to Parkinson’s disease only, Parkinson’s disease anxiety, and Parkinson’s disease depression patients. Pain interference, pain severity, and pain disability is greater among Parkinson’s disease patients with anxiety and depression, in comparison to Parkinson’s disease patients without anxiety and depression. On the contrary, the prevalence of restless legs syndrome was not found to be relevant.


Sign in / Sign up

Export Citation Format

Share Document